StockData

Caris Life Sciences vs Veracyte

CAI and VCYT side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CAI and VCYT compare

Caris Life Sciences is the larger company, worth 2.9 times as much as Veracyte ($5.6B against $1.9B).

Caris Life Sciences grew revenue faster over the last twelve months (61.5% versus 17.3% for Veracyte).

Veracyte keeps more of each dollar of sales as profit, with a net margin of 20.4% compared with 9.2% at Caris Life Sciences.

Veracyte scores higher on the StockData Score (16 against 7 for Caris Life Sciences), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCAIVCYT
Size and price
Market cap$5.6B$1.9B
Share price$19.94$24.23
Change, 1 year−16.4%−38.4%
Change, 5 years–−41.7%
Beta (5Y)2.531.92
Employees1,846755
StockData Score
Total score716 (better)
Valuation score04 (better)
Growth score13 (better)
Performance score33
Health score36 (better)
Dividend score00
Valuation
P/E–17.3×
P/S5.4×3.5× (better)
P/B8.8×1.4× (better)
EV/EBITDA36.5×13.0× (better)
P/FCF195×11.7× (better)
FCF yield0.51%8.5% (better)
Fair value$10.35$36.51
Margin of safety−92.6%33.6% (better)
Growth
Revenue growth (TTM)61.5% (better)17.3%
Revenue growth, 5Y average–34.5%
Net income growth (TTM)–335%
EPS growth (TTM)–324%
Profitability
Gross margin–71.7%
Operating margin13.4%18.8% (better)
Net margin9.2%20.4% (better)
FCF margin2.8%29.5% (better)
Return on equity17.2% (better)8.8%
Return on invested capital26.8% (better)10.0%
Financial health
Debt / equity0.61 (better)0.00
Net debt / EBITDA1.79–
Interest coverage3.3×–
Current ratio6.719.16 (better)
Altman Z-score4.7312.65 (better)
Piotroski F-score67 (better)
Dividends and buybacks
Buyback yield0.56%–
Shareholder yield0.56% (better)0.00%
Ownership
Held by institutions54.5%111%
Held by insiders64.1%1.7%
Insider net buying, 12 months−$27.4M−$18.6M (better)
Superinvestors holding2–
Short interest, % of float11.3%12.1%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.